NANOVIRICIDES, INC. Stock Split Ratio
NANOVIRICIDES, INC. (NNVC) had Stock Split Ratio of 2000.00% as of 2019-09-24, per its 10-K filed 2020-10-13.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2020-10-13
- NANOVIRICIDES, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2015 was 350.00%, a 0.00% change from fiscal 2014.
- NANOVIRICIDES, INC. stockholders' equity note, stock split, conversion ratio for fiscal 2014 was 350.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio 0 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 9 month | Stockholders' Equity Note, Stock Split, Conversion Ratio 12 month |
|---|---|---|---|---|---|
| 2019-09-24 | 2000.00% 10-K · filed 2020-10-13 | ||||
| 2015-06-30 | 350.00% 10-K · filed 2015-09-14 | ||||
| 2014-06-30 | 350.00% 10-K · filed 2015-02-23 | ||||
| 2014-03-31 | 350.00% 10-Q · filed 2014-05-15 | ||||
| 2013-09-09 | 350.00% 10-Q/A · filed 2015-02-23 | ||||
| 2010-09-30 | 350.00% 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |